Wen Shi Lee and Olga Amengual.
Cells targeting therapy in the management of systemic lupus erythematosus.
Immunological Medicine.
Accepted 25 November,2019 in press
Wen Shi Lee and Olga Amengual.
Cells targeting therapy in the management of systemic lupus erythematosus.
Immunological Medicine.
Accepted 25 November,2019 in press
Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Kudo T, Hattanda F, Nishio S, Masuda S, Tomaru U, Kondo T, Atsumi T, Ishizu A.
Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection.
Journal of Autoimmunity. 2019. PMID: 31883830
Maeda T, Kitamura S, Yanagi T, Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.
Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.
Journal of Cutaneous Immunology and Allergy. 2019.
Metin-Armagan D, Comunoglu N, Bulut G, Kadioglu P, Kameda H, Gazioglu N, Tanriover N, Ozturk M.
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Endocrine Pathology. 2019. PMID: 31828584
Nomoto H, Montemurro C, Pei L, Rosenberger M, Furterer A, Coppola G, Nadel B, Pellegrini M, Gurlo T, Butler PC, Tudzarova S.
Activation of the HIF1α/PFKFB3 stress response pathway in beta-cells in type 1 diabetes.
Diabetologia. 2019. PMID: 31720731
Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC.
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.
Case Reports in Endocrinology. 2019.
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes, Obesity and Metabolism. 2019. PMID: 31486230
Cho KY, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Diabetes & Metabolism Journal. 2019. PMID: 31769240